Skip to main content
. 2024 Oct 18;52:102131. doi: 10.1016/j.rmcr.2024.102131

Fig. 2.

Fig. 2

The clinical course of over 15 months of persistent active SARS-CoV-2 infection in a patient receiving anti-CD20 therapy for follicular lymphoma.